1
|
de Montalembert M, Anderson A, Costa FF, Inusa BPD, Jastaniah W, Kunz JB, Tinga B, Ingoli E, James J, Hartfield R, Beaubrun A, Lartey B, Odame I. Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease. Eur J Haematol 2024. [PMID: 38634725 DOI: 10.1111/ejh.14211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 03/20/2024] [Accepted: 03/26/2024] [Indexed: 04/19/2024]
Abstract
OBJECTIVES Sickle cell disease (SCD) is an inherited disorder that causes lifelong complications, substantially impacting the physical and emotional well-being of patients and their caregivers. Studies investigating the effects of SCD on quality of life (QOL) are often limited to individual countries, lack SCD-specific QOL questionnaires, and exclude the caregiver experience. The SHAPE survey aimed to broaden the understanding of the global burden of SCD on patients and their caregivers and to capture the viewpoint of healthcare providers (HCPs). METHODS A total of 919 patients, 207 caregivers, and 219 HCPs from 10, 9, and 8 countries, respectively, answered a series of closed-ended questions about their experiences with SCD. RESULTS The symptoms most frequently reported by patients were fatigue/tiredness (84%) and pain/vaso-occlusive crises (71%). Patients' fatigue/tiredness had one of the greatest impacts on both patients' and caregivers' QOL. On average, patients and caregivers reported missing 7.5 days and 5.0 days per month, respectively, of school or work. HCPs reported a need for effective tools to treat fatigue/tiredness and a desire for more support to educate patients on long-term SCD-related health risks. CONCLUSIONS The multifaceted challenges identified using the SHAPE survey highlight the global need to improve both patient and caregiver QOL.
Collapse
Affiliation(s)
- Mariane de Montalembert
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
| | - Alan Anderson
- Department of Pediatric Hematology-Oncology, PRISMA Health Comprehensive SCD Program, University of South Carolina School of Medicine, Greenville, South Carolina, USA
| | - Fernando F Costa
- Haematology and Haemotherapy Centre, School of Medicine, University of Campinas - UNICAMP, Campinas, São Paulo, Brazil
| | - Baba P D Inusa
- Department of Paediatric Haematology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK
| | - Wasil Jastaniah
- Department of Pediatric Oncology Hematology Bone Marrow Transplant, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia
| | - Joachim B Kunz
- Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center Heidelberg (KiTZ), University of Heidelberg, Heidelberg, Germany
| | - Biba Tinga
- Sickle Cell Disease Association of Canada, Toronto, Canada
| | - Elvie Ingoli
- IST e.V., German Sickle Cell Disease and Thalassaemia Association, Eschweiler, Germany
| | | | - Regina Hartfield
- Sickle Cell Disease Association of America, Inc., Hanover, Maryland, USA
| | | | | | - Isaac Odame
- Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
| |
Collapse
|
2
|
Roth AR, Lazris A, Haskell PPBH, James J. Avoiding Delays in Diagnosing Endometriosis. Am Fam Physician 2024; 109:268-270. [PMID: 38574219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2024]
Affiliation(s)
- Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, New York
| | | | | | | |
Collapse
|
3
|
Giannotti E, Van Nijnatten TJA, Chen Y, Bicchierai G, Nori J, De Benedetto D, Lalji U, Lee AHS, James J. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast. Clin Radiol 2024:S0009-9260(24)00090-4. [PMID: 38383254 DOI: 10.1016/j.crad.2024.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 01/22/2024] [Accepted: 01/25/2024] [Indexed: 02/23/2024]
Abstract
AIM To assess the performance of contrast-enhanced mammography (CEM) in the preoperative staging of invasive lobular carcinoma (ILC) of the breast. MATERIALS AND METHODS The present study was a multicentre, multivendor, multinational retrospective study of women with a histological diagnosis of ILC who had undergone CEM from December 2013 to December 2021. Index lesion size and multifocality were recorded for two-dimensional (2D) mammography, CEM, and when available magnetic resonance imaging (MRI). Comparison with histological data was undertaken for women treated by primary surgical excision. Pearson correlation coefficients and Bland-Altman's analysis of agreement were used to assess differences with a significance level of 0.05. RESULTS One hundred and fifteen ILC lesions were included, 46 (40%) presented symptomatically and 69 were screening detected. CEM demonstrated superior sensitivity when compared to standard mammography. The correlation between the histological size measured on the surgical excision specimen size was greater than with standard mammography (r=0.626 and 0.295 respectively, p=0.001), with 19% of lobular carcinomas not visible without a contrast agent. The sensitivity of CEM for multifocal disease was greater than standard mammography (70% and 20% respectively, p<0.0001). CEM overestimated tumour size by an average of 1.5 times, with the size difference increasing for larger tumour. When MRI was performed (n=22), tumour size was also overestimated by an average of 1.3 times. The degree of size overestimation was similar for both techniques, with the tumour size on CEM being on average 0.5 cm larger than MRI. CONCLUSION CEM is a useful tool for the local staging of lobular carcinomas and could be an alternative to breast MRI.
Collapse
Affiliation(s)
- E Giannotti
- Cambridge Breast Unit, Addenbrooke's Cambridge University Hospital NHS Foundation Trust, Cambridge, UK; Nottingham Breast Institute Nottingham University Hospital NHS Trust, Nottingham, UK.
| | - T J A Van Nijnatten
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands; School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands
| | - Y Chen
- University of Nottingham, School of Medicine, Division of Cancer and Stem Cells, City Hospital Campus, Nottingham, UK
| | - G Bicchierai
- Breast Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
| | - J Nori
- Breast Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
| | - D De Benedetto
- Breast Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
| | - U Lalji
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands
| | - A H S Lee
- Histopathology Department, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK
| | - J James
- Nottingham Breast Institute Nottingham University Hospital NHS Trust, Nottingham, UK
| |
Collapse
|
4
|
Fokin AI, Boutillon A, James J, Courtois L, Vacher S, Simanov G, Wang Y, Polesskaya A, Bièche I, David NB, Gautreau AM. Inactivating negative regulators of cortical branched actin enhances persistence of single cell migration. J Cell Sci 2024; 137:jcs261332. [PMID: 38059420 DOI: 10.1242/jcs.261332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Accepted: 11/30/2023] [Indexed: 12/08/2023] Open
Abstract
The Rac1-WAVE-Arp2/3 pathway pushes the plasma membrane by polymerizing branched actin, thereby powering membrane protrusions that mediate cell migration. Here, using knockdown (KD) or knockout (KO), we combine the inactivation of the Arp2/3 inhibitory protein arpin, the Arp2/3 subunit ARPC1A and the WAVE complex subunit CYFIP2, all of which enhance the polymerization of cortical branched actin. Inactivation of the three negative regulators of cortical branched actin increases migration persistence of human breast MCF10A cells and of endodermal cells in the zebrafish embryo, significantly more than any single or double inactivation. In the triple KO cells, but not in triple KD cells, the 'super-migrator' phenotype was associated with a heterogenous downregulation of vimentin (VIM) expression and a lack of coordination in collective behaviors, such as wound healing and acinus morphogenesis. Re-expression of vimentin in triple KO cells largely restored normal persistence of single cell migration, suggesting that vimentin downregulation contributes to the maintenance of the super-migrator phenotype in triple KO cells. Constant excessive production of branched actin at the cell cortex thus commits cells into a motile state through changes in gene expression.
Collapse
Affiliation(s)
- Artem I Fokin
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Arthur Boutillon
- INSERM U1182, CNRS UMR7645, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - John James
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Laura Courtois
- Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
| | - Sophie Vacher
- Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
| | - Gleb Simanov
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Yanan Wang
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Anna Polesskaya
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Ivan Bièche
- Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
| | - Nicolas B David
- INSERM U1182, CNRS UMR7645, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - Alexis M Gautreau
- CNRS UMR7654, Ecole Polytechnique, Institut Polytechnique de Paris, 91120 Palaiseau, France
| |
Collapse
|
5
|
Wolf ER, Vadlamudi N, Schefft M, Haskell H, James J. Overuse of Antireflux Medications in Infants. Am Fam Physician 2023; 108:614-616. [PMID: 38215422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2024]
Affiliation(s)
- Elizabeth R Wolf
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia
| | - Naren Vadlamudi
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia
| | - Matthew Schefft
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia
| | | | | |
Collapse
|
6
|
Herness J, Sanders J, James J. Environmental Interventions for Preventing Falls in Older People Living in the Community. Am Fam Physician 2023; 108:450-451. [PMID: 37983695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2023]
Affiliation(s)
- Joel Herness
- David Grant USAF Medical Center, Travis Air Force Base, California
| | - Jacob Sanders
- David Grant USAF Medical Center, Travis Air Force Base, California
| | | |
Collapse
|
7
|
James J, Robinson C, Mason C, Richards C, West K, Morgan B. Impact of the COVID-19 pandemic on a post-mortem CT service for adult non-suspicious death. Clin Radiol 2023; 78:822-831. [PMID: 37827592 DOI: 10.1016/j.crad.2023.03.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 03/14/2023] [Accepted: 03/23/2023] [Indexed: 10/14/2023]
Abstract
Due to the COVID-19 pandemic, the post-mortem computed tomography (PMCT) service was expanded from three to seven cases per day to help mortuary services and avoid invasive autopsy. Additional targeted angiography and pulmonary ventilation procedures were stopped and triage rules relaxed to allow more indications to be scanned, including those requiring toxicology. A service evaluation was performed for the first 3-months of the COVID-19 pandemic compared to the equivalent period the previous year to study the impact of these changes. It was found that, despite the increase in deaths regionally, coronial referrals remained about 100 per month, a reduction in referral rate. The number undergoing PMCT rose from 28% to 74% of cases. Turnaround time remained the same. For cases triaged to PMCT, the need for subsequent autopsy increased from 7.9% to 15.8%. No significant changes were seen in diagnosis rates, including cardiac or respiratory. There was an increase in patients with coronary death without severe coronary calcification who underwent autopsy after PMCT. These may have been diagnosed by targeted coronary angiography. Fifty-three cases requiring toxicology/biochemistry had PMCT, with 38 having PMCT only. In 8/11 (72.7%) cases with normal PMCT and toxicology as the key diagnostic test, autopsy was performed prior to results. This suggests the pathology team were reluctant to risk an "unascertained" outcome. This study shows that it is possible to increase PMCT services by widening referral criteria and by limiting the use of enhanced imaging techniques, without significantly changing diagnosis rates of key diseases; however, selectively restarting targeted angiography may help avoid autopsy in some cases.
Collapse
Affiliation(s)
- J James
- Imaging Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
| | - C Robinson
- Imaging Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
| | - C Mason
- The Coroner's Court, Town Hall, Town Hall Square, Leicester, UK
| | - C Richards
- Histopathology Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
| | - K West
- Histopathology Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
| | - B Morgan
- Department of Life Sciences, University of Leicester, Radiology Department, Leicester Royal Infirmary, Infirmary Square, Leicester LE2 7LX, UK.
| |
Collapse
|
8
|
Duff C, Kennedy L, Ryan E, James J, Binchy A, O'Donovan D. Introducing LISA: Less Invasive Surfactant Administration. Ir Med J 2023; 116:854. [PMID: 37874313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/25/2023]
|
9
|
Cothern JA, Edinger ML, Smith DK, James J. Aspirin Use and the Risk of Mortality in Patients With Hypertension. Am Fam Physician 2023; 108:349-350. [PMID: 37843941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2023]
|
10
|
Lam CW, Castranova V, Driscoll K, Warheit D, Ryder V, Zhang Y, Zeidler-Erdely P, Hunter R, Scully R, Wallace W, James J, Crucian B, Nelman M, McCluskey R, Gardner D, Renne R, McClellan R. A review of pulmonary neutrophilia and insights into the key role of neutrophils in particle-induced pathogenesis in the lung from animal studies of lunar dusts and other poorly soluble dust particles. Crit Rev Toxicol 2023; 53:441-479. [PMID: 37850621 PMCID: PMC10872584 DOI: 10.1080/10408444.2023.2258925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Accepted: 08/27/2023] [Indexed: 10/19/2023]
Abstract
The mechanisms of particle-induced pathogenesis in the lung remain poorly understood. Neutrophilic inflammation and oxidative stress in the lung are hallmarks of toxicity. Some investigators have postulated that oxidative stress from particle surface reactive oxygen species (psROS) on the dust produces the toxicopathology in the lungs of dust-exposed animals. This postulate was tested concurrently with the studies to elucidate the toxicity of lunar dust (LD), which is believed to contain psROS due to high-speed micrometeoroid bombardment that fractured and pulverized lunar surface regolith. Results from studies of rats intratracheally instilled (ITI) with three LDs (prepared from an Apollo-14 lunar regolith), which differed 14-fold in levels of psROS, and two toxicity reference dusts (TiO2 and quartz) indicated that psROS had no significant contribution to the dusts' toxicity in the lung. Reported here are results of further investigations by the LD toxicity study team on the toxicological role of oxidants in alveolar neutrophils that were harvested from rats in the 5-dust ITI study and from rats that were exposed to airborne LD for 4 weeks. The oxidants per neutrophils and all neutrophils increased with dose, exposure time and dust's cytotoxicity. The results suggest that alveolar neutrophils play a critical role in particle-induced injury and toxicity in the lung of dust-exposed animals. Based on these results, we propose an adverse outcome pathway (AOP) for particle-associated lung disease that centers on the crucial role of alveolar neutrophil-derived oxidant species. A critical review of the toxicology literature on particle exposure and lung disease further supports a neutrophil-centric mechanism in the pathogenesis of lung disease and may explain previously reported animal species differences in responses to poorly soluble particles. Key findings from the toxicology literature indicate that (1) after exposures to the same dust at the same amount, rats have more alveolar neutrophils than hamsters; hamsters clear more particles from their lungs, consequently contributing to fewer neutrophils and less severe lung lesions; (2) rats exposed to nano-sized TiO2 have more neutrophils and more severe lesions in their lungs than rats exposed to the same mass-concentration of micron-sized TiO2; nano-sized dust has a greater number of particles and a larger total particle-cell contact surface area than the same mass of micron-sized dust, which triggers more alveolar epithelial cells (AECs) to synthesize and release more cytokines that recruit a greater number of neutrophils leading to more severe lesions. Thus, we postulate that, during chronic dust exposure, particle-inflicted AECs persistently release cytokines, which recruit neutrophils and activate them to produce oxidants resulting in a prolonged continuous source of endogenous oxidative stress that leads to lung toxicity. This neutrophil-driven lung pathogenesis explains why dust exposure induces more severe lesions in rats than hamsters; why, on a mass-dose basis, nano-sized dusts are more toxic than the micron-sized dusts; why lung lesions progress with time; and why dose-response curves of particle toxicity exhibit a hockey stick like shape with a threshold. The neutrophil centric AOP for particle-induced lung disease has implications for risk assessment of human exposures to dust particles and environmental particulate matter.
Collapse
Affiliation(s)
- Chiu-wing Lam
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
- Biomedical & Environmental Research Department, KBR Toxicology & Environmental Chemistry, Houston, TX, USA
- Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, TX, USA
| | - Vincent Castranova
- Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA
| | - Kevin Driscoll
- Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA
| | | | - Valerie Ryder
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
| | - Ye Zhang
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
- Utilization and Life Sciences Office, Kennedy Space Center, Merritt Island, FL, USA
| | - Patti Zeidler-Erdely
- Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA
| | - Robert Hunter
- Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, TX, USA
| | - Robert Scully
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
- Biomedical & Environmental Research Department, KBR Toxicology & Environmental Chemistry, Houston, TX, USA
| | - William Wallace
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
- Biomedical & Environmental Research Department, KBR Toxicology & Environmental Chemistry, Houston, TX, USA
| | - John James
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
| | - Brian Crucian
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
| | - Mayra Nelman
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, USA
- Biomedical & Environmental Research Department, KBR Toxicology & Environmental Chemistry, Houston, TX, USA
| | | | | | - Roger Renne
- Roger Renne ToxPath Consulting Inc., Sumner, WA, USA
| | - Roger McClellan
- Toxicology and Human Health Risk Analysis, Albuquerque, NM, USA
| |
Collapse
|
11
|
Lazris A, Roth A, Haskell H, James J. Diagnostic Overshadowing: When Cognitive Biases Can Harm Patients. Am Fam Physician 2023; 108:292-294. [PMID: 37725463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2023]
Affiliation(s)
| | - Alan Roth
- Jamaica Hospital Medical Center, Jamaica, New York
| | | | | |
Collapse
|
12
|
Bulik CM, Micali N, MacDermod CM, Qi B, Munn-Chernoff MA, Thornton LM, White J, Dinkler L, Pisetsky EM, Johnson J, Devine KR, Ortiz SN, Silverman AE, Berthold N, Dumain A, Guintivano J, Halvorsen M, James J. Arfid Genes and Environment (ARFID-GEN): Study Protocol. Res Sq 2023:rs.3.rs-3186174. [PMID: 37693386 PMCID: PMC10491341 DOI: 10.21203/rs.3.rs-3186174/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/12/2023]
Abstract
Background The Avoidant Restrictive Food Intake Disorder Genes and Environment (ARFID-GEN) study is a study of genetic and environmental factors that contribute to risk for developing ARFID in children and adults. Methods A total of 3,000 children and adults with ARFID from the United States will be included. Parents/guardians and their children with ARFID (ages 7 to 17) and adults with ARFID (ages 18+) will complete comprehensive online consent, parent verification of child assent (when applicable), and phenotyping. Enrolled participants with ARFID will submit a saliva sample for genotyping. A genome-wide association study of ARFID will be conducted. Discussion ARFID-GEN, a large-scale genetic study of ARFID, is designed to rapidly advance the study of the genetics of eating disorders. We will explicate the genetic architecture of ARFID relative to other eating disorders and to other psychiatric, neurodevelopmental, and metabolic disorders and traits. Our goal is for ARFID to deliver "actionable" findings that can be transformed into clinically meaningful insights. Trial registration ARFID-GEN is a registered clinical trial: clinicaltrials.gov NCT05605067.
Collapse
Affiliation(s)
| | - Nadia Micali
- Mental Health Services of the Capital Region of Denmark
| | | | - Baiyu Qi
- University of North Carolina at Chapel Hill
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - J James
- University of North Carolina at Chapel Hill
| |
Collapse
|
13
|
Daniel CL, Fillingim S, James J, Bassler J, Lee A. Long COVID prevalence and associated characteristics among a South Alabama population. Public Health 2023; 221:135-141. [PMID: 37451202 DOI: 10.1016/j.puhe.2023.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 05/11/2023] [Accepted: 06/06/2023] [Indexed: 07/18/2023]
Abstract
OBJECTIVES Long COVID can significantly impact a patient's quality of life. Defined as persistence or emergence of symptoms 4+ weeks after initial COVID-19 diagnosis, long COVID can result in functional impairments, pulmonary issues, and neuropsychiatric conditions, among others. This study aims to identify long COVID risk factors and prevalence in a south Alabama (US) patient population. STUDY DESIGN This was a longitudinal cohort study. METHODS Postdiagnosis standardized phone interviews (baseline, 6 months, and 12 months) from April 2020 to July 2021 with patients testing positive through a large healthcare system. Interviews gathered data on sociodemographics, comorbidities, acute illness, and long COVID. Relationships between 1+ ongoing symptoms and variables of interest were assessed using a generalized estimating equation to conduct multivariate analysis. RESULTS Of the 516 participants, most were female (65%) and African American (57%, n = 293), with a median (interquartile range) age of 41.1 (25.3-54.6) years. Retention was 70% (n = 359) at 6 months and 58% (n = 301) at 12 months. Participants reporting 1+ persistent symptoms were 20% and 17% at 6 and 12 months, respectively. Illness severity (P < 0.0001) and COVID-related emergency room visit with hospital admission at the time of diagnosis (P = 0.0018) were significantly associated with increased long COVID risk. CONCLUSIONS This study found substantial rates of long COVID within our population, with stable rates at 6 and 12 months, indicating illness persistence. Our findings support growing concern for long COVID as a persistent issue within the medical community, with potential to impact patient health for years. Larger, more uniform studies are required to further characterize disease risk factors and clinical course to inform the disease management.
Collapse
Affiliation(s)
- C L Daniel
- University of South Alabama, College of Medicine at Mobile, AL, USA.
| | - S Fillingim
- University of South Alabama, College of Medicine at Mobile, AL, USA
| | - J James
- University of South Alabama, College of Medicine at Mobile, AL, USA
| | - J Bassler
- University of Alabama at Birmingham, AL, USA
| | - A Lee
- University of South Alabama, College of Medicine at Mobile, AL, USA
| |
Collapse
|
14
|
Roth AR, Lazris A, Haskell H, James J. Overdiagnosis of CKD in Older Adults: Unnecessary Interventions, Costs, and Worry. Am Fam Physician 2023; 107:657-658. [PMID: 37327176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Affiliation(s)
- Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, New York
| | | | | | | |
Collapse
|
15
|
McDonald J, Kornish J, Stevenson DA, Hanson-Kahn A, Balch H, James J, Naik H, Whitehead KJ. Frequency of Epistaxis and Telangiectasia in patients with Hereditary Hemorrhagic Telangiectasia (HHT) in comparison with the General Population: Curaçao Diagnostic Criteria Revisited. Genet Med 2023:100865. [PMID: 37125633 DOI: 10.1016/j.gim.2023.100865] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2022] [Revised: 04/16/2023] [Accepted: 04/18/2023] [Indexed: 05/02/2023] Open
Abstract
PURPOSE The Curaçao criteria are well-established diagnostic criteria for HHT but lack details regarding a predictive presentation of epistaxis and telangiectasias. This study collects and compares data in HHT and population cohorts to inform the application of these criteria. METHODS In-person interviews regarding epistaxis and targeted examination for telangiectases in a general population cohort (n=204) and an HHT cohort (n=432). RESULTS Frequency of epistaxis, rather than intensity or duration, was the best discriminator of HHT. A cut-off of 4 or more nosebleeds per year, alone, yielded a diagnostic sensitivity of 97%, and specificity of 84%. The mean number of telangiectases at the sites investigated was 0.4 in the general population cohort and 26.5 in the HHT cohort. The most distinctive sites for telangiectases in HHT were lips and palmar fingers; whereas telangiectases of the face and dorsum of the hand were comparable in both cohorts. CONCLUSION We propose that the Curaçao criteria be modified to include the following cutoffs: 1) epistaxis frequency of 4 or more nosebleeds per year, 2) telangiectasia count of at least 2 in characteristic locations (palmar aspect of fingers, lips and oral cavity); and that cutaneous telangiectases at other sites not be considered relevant for diagnostic purposes.
Collapse
Affiliation(s)
- Jamie McDonald
- Department of Pathology, University of Utah, Salt Lake City, Utah
| | - Jenna Kornish
- Department of Genetics, Stanford University, Stanford, California
| | - David A Stevenson
- Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California
| | - Andrea Hanson-Kahn
- Department of Genetics and Division of Medical Genetics, Stanford University, Stanford, California
| | - Heather Balch
- Department of Internal Medicine, University of Utah, Salt Lake City, Utah
| | - John James
- University of Utah School of Medicine, Salt Lake City, Utah
| | - Hetanshi Naik
- Department of Genetics, Stanford University, Stanford, California
| | - Kevin J Whitehead
- Division of Cardiovascular Medicine, Department of Medicine, HHT Center, University of Utah, Salt Lake City, Utah.
| |
Collapse
|
16
|
Fulford RS, Houghton K, James J, Russell M. In situ differences in nitrogen cycling related to presence of submerged aquatic vegetation in a Gulf of Mexico estuary. Ecosphere 2022. [DOI: 10.1002/ecs2.4290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Affiliation(s)
- R. S. Fulford
- Office of Research and Development US Environmental Protection Agency Gulf Breeze Florida USA
| | - K. Houghton
- Centers for Disease Control and Prevention Atlanta Georgia USA
| | - J. James
- Office of Research and Development US Environmental Protection Agency Gulf Breeze Florida USA
| | - M. Russell
- Office of Research and Development US Environmental Protection Agency Gulf Breeze Florida USA
| |
Collapse
|
17
|
Lazris A, Roth AR, Haskell H, James J. Overdiagnosis of Nonalcoholic Fatty Liver Disease. Am Fam Physician 2022; 106:704-707. [PMID: 36521471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Affiliation(s)
| | - Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, New York
| | | | | |
Collapse
|
18
|
Hong AWJ, James J, Stoney D, Law M. 'Breast Cosmesis After Breast-Conserving Therapy' Who is the Judge, Patient or Surgeon? World J Surg 2022; 46:3051-3061. [PMID: 36169705 DOI: 10.1007/s00268-022-06745-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/10/2022] [Indexed: 01/14/2023]
Abstract
INTRODUCTION More than 80% of newly diagnosed breast cancers are managed with breast-conserving therapy (BCT). Preservation of cosmetically acceptable breasts is an inherent aim of all breast-conserving efforts-this can, however, be difficult to assess objectively. Compounding this is the difference in perception of breast cosmesis between patients and surgeons. This study compares the concordance of a new subscale-based cosmetic score (TCS) with the patient's perception. METHOD Eastern Health Breast and Cancer Centre conducted this study on patients who had completed their BCT and radiotherapy. Participation was voluntary and involved permitting an assessor (breast surgery fellow or consultant) to grade cosmetic outcomes to generate a Total Cosmesis Score (TCS). The patients blinded to this assessment were then asked to complete the postoperative segment of the BCT module of the Breast-Q questionnaire. TCS from surgeon assessment was compared against patient assessment (questions BQ1i and BQ1k specifically). Cohen's kappa was calculated to define the strength of the inter-rater agreement. RESULTS One hundred twelve patients with a mean age of 59 (range 27-89) participated in the study. TCS was low in 26% and high in 74% of participants. 76% and 69% of participants were satisfied when answering Breast-Q questions 'How your lumpectomy breast looks?' and 'How you look in the mirror unclothed?' respectively (Cohen's k = 0.464, 95% CI 0.337-0.591, p < 0.01). The agreement between the TCS and the patient assessment was poor (Cohen's k = 0.172, 95% CI - 0.020-2.093, p = 0.067). CONCLUSION Cosmetic outcomes scored using TCS by surgeons do not match patient's own assessment of the cosmetic result.
Collapse
Affiliation(s)
- Alton Wern Jie Hong
- Eastern Health Breast and Cancer Centre, 8 Arnold Street, Box Hill, Melbourne, VIC, 3128, Australia.
| | - J James
- Eastern Health Breast and Cancer Centre, 8 Arnold Street, Box Hill, Melbourne, VIC, 3128, Australia
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
| | - D Stoney
- Eastern Health Breast and Cancer Centre, 8 Arnold Street, Box Hill, Melbourne, VIC, 3128, Australia
| | - M Law
- Eastern Health Breast and Cancer Centre, 8 Arnold Street, Box Hill, Melbourne, VIC, 3128, Australia
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
| |
Collapse
|
19
|
Odame I, Anderson A, Costa F, Inusa B, Jastaniah W, Kuntz J, Alkhadem Z, Tinga B, Ba D, Ingoli E, James J, Clark A, Alfa Cissé O, Beaubrun A, Lartey B, De Montalembert M. Étude SHAPE (Sickle Cell Health Awareness, Perspectives and Experiences) : enquête sur le fardeau de la drépanocytose et les besoins non satisfaits rapportés par les patients et les aidants. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
20
|
Glaseroff A, Lindsay A, Haskell H, James J. Collaborative Care for Depression in Older Adults. Am Fam Physician 2022; 106:318-320. [PMID: 36126014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Alan Glaseroff
- Stanford Clinical Excellence Research Center, Stanford, California
| | - Ann Lindsay
- Stanford University School of Medicine, Stanford, California
| | | | | |
Collapse
|
21
|
James J, Warwick A. 393 Communication in Catheter Care: A Closed Loop Audit of Catheter Documentation in Emergency Presentations to a Tertiary Urology Centre. Br J Surg 2022. [DOI: 10.1093/bjs/znac269.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Abstract
Aim
Estimates suggest that 20% of patients admitted to hospital undergo catheterisation, some of whom will end up discharged with catheters. Clear documentation assists in communication between hospital and community teams. The EAUN has identified key areas for documentation including use of care plans. We audited compliance with documentation pre- and post-intervention in a tertiary urology department
Method
Emergency patients presenting to urology were identified over a 3-week period pre-intervention and 3-weeks post-intervention. Clinical notes were audited for documentation of catheterisation. Domains assessed included indication, type/size of catheter, catheter balloon volume, residual volume, urinalysis, and plan. Use of care plans was also audited. Intervention involved development and deployment of a poster as well as discussion with staff.
Results
In total 274 patients were identified. 47 catheters were inserted pre-intervention, with variable compliance in documentation throughout the domains with similar pattern of compliance noted in the post-intervention group (n=42). Compliance was highest in size of catheter and indication for insertion, with urinalysis the most frequently missed domain (14.9% pre-intervention, 9.5% post-intervention). The only area with significant improvement was documentation of balloon volume (p=0.0019). Use of the care plan showed some minor improvement but was generally poor.
Conclusion
Use of visual cues did not result in approvement in documentation. Discussion with the teams suggested awareness of the domains and care plan however, they didn't necessarily think of them at time of documentation. As such a text prompt for the electronic notes is now in development and further audit to assess impact pending.
Collapse
Affiliation(s)
- J James
- NHS Lothian , Edinburgh , United Kingdom
| | - A Warwick
- NHS Lothian , Edinburgh , United Kingdom
| |
Collapse
|
22
|
Roth AR, Lazris A, Haskell H, James J. Overuse of Interventional Procedures for Low Back Pain. Am Fam Physician 2022; 105:667-670. [PMID: 35704820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Affiliation(s)
- Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, NY, USA
| | | | | | | |
Collapse
|
23
|
Osunkwo I, James J, El‐Rassi F, Nero A, Minniti CP, Trimnell C, Paulose J, Ramscar N, Bailey T, Rajkovic‐Hooley O, Andemariam B. Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey. Am J Hematol 2022; 97:1055-1064. [PMID: 35472249 PMCID: PMC9540420 DOI: 10.1002/ajh.26576] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 04/10/2022] [Accepted: 04/17/2022] [Indexed: 11/26/2022]
Abstract
The international Sickle Cell World Assessment Survey (SWAY) reported a high impact of sickle cell disease (SCD) on patients' daily lives globally. In this study, we analyzed whether the reported burden differed between patients from the USA (n = 384) and other high‐income (HI; n = 820) or low‐ to middle‐income (LMI; n = 941) countries. We assessed symptoms and complications, incidence/management of vaso‐occlusive crises (VOCs), treatment utilization/satisfaction, and the impact of SCD on education/employment. Certain symptoms (bone aches, insomnia, and joint stiffness) and complications (swollen/painful fingers/toes, gallstones, vision problems, blood clots, and asthma) were reported proportionally more by patients in the USA than in the HI/LMI countries. Self‐reported VOCs were more common (mean [SD]: 7.1 [5.7] vs. 5.5 [8.9] and 4.4 [4.6] in the previous 12 months) and were managed more often by hospitalization (52% vs. 24% and 32%) in the USA than the HI and LMI countries. A higher proportion of patients from the USA than the HI/LMI countries reported a negative impact of SCD on their employment/schooling. Although high overall satisfaction with current treatments was reported globally, most patients indicated a strong desire for alternative pain medications. There are likely several reasons for the relatively high patient‐reported burden in the USA group compared with the HI/LMI countries, including an older population and differences in newborn screening programs and pediatric/adult transition of care. It is clear that there is an urgent need for improved understanding and management of SCD globally, not just in the USA.
Collapse
Affiliation(s)
- Ifeyinwa Osunkwo
- Sickle Cell Disease Enterprise, The Levine Cancer Institute, Atrium Health Charlotte North Carolina USA
| | | | - Fuad El‐Rassi
- Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System Atlanta Georgia USA
| | - Alecia Nero
- University of Texas Southwestern Medical Center Dallas Texas USA
| | | | | | - Jincy Paulose
- Novartis Pharmaceuticals Corporation East Hanover New Jersey USA
| | | | | | | | - Biree Andemariam
- New England Sickle Cell Institute University of Connecticut Health Farmington Connecticut USA
| |
Collapse
|
24
|
Kasioulis I, Dady A, James J, Prescott A, Halley PA, Storey KG. A lateral protrusion latticework connects neuroepithelial cells and is regulated during neurogenesis. J Cell Sci 2022; 135:274540. [PMID: 35217862 PMCID: PMC8995095 DOI: 10.1242/jcs.259897] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2022] [Accepted: 02/11/2022] [Indexed: 12/04/2022] Open
Abstract
Dynamic contacts between cells within the developing neuroepithelium are poorly understood but play important roles in cell and tissue morphology and cell signalling. Here, using live-cell imaging and electron microscopy we reveal multiple protrusive structures in neuroepithelial apical endfeet of the chick embryonic spinal cord, including sub-apical protrusions that extend laterally within the tissue, and observe similar structures in human neuroepithelium. We characterise the dynamics, shape and cytoskeleton of these lateral protrusions and distinguish them from cytonemes, filopodia and tunnelling nanotubes. We demonstrate that lateral protrusions form a latticework of membrane contacts between non-adjacent cells, depend on actin but not microtubule dynamics, and provide a lamellipodial-like platform for further extending fine actin-dependent filipodia. We find that lateral protrusions depend on the actin-binding protein WAVE1 (also known as WASF1): misexpression of mutant WAVE1 attenuated protrusion and generated a round-ended apical endfoot morphology. However, this did not alter apico-basal cell polarity or tissue integrity. During normal neuronal delamination, lateral protrusions were withdrawn, but precocious protrusion loss induced by mutant WAVE1 was insufficient to trigger neurogenesis. This study uncovers a new form of cell-cell contact within the developing neuroepithelium, regulation of which prefigures neuronal delamination. This article has an associated First Person interview with the first author of the paper.
Collapse
|
25
|
Schefft M, Wolf ER, Quinonez R, Haskell H, James J. Appropriate Use of Electrocardiography in Preparticipation Physical Evaluations. Am Fam Physician 2022; 105:302-306. [PMID: 35289568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- Matthew Schefft
- Children's Hospital of Richmond at VCU Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
| | - Elizabeth R Wolf
- Children's Hospital of Richmond at VCU Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
| | | | | | | |
Collapse
|
26
|
Fragapane T, Binchy A, James J, Letshwiti JB. Implementing Safety Huddles During the COVID-19 Pandemic: The Neo-SAFE Project. Ir Med J 2022; 115:548. [PMID: 35420010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- T Fragapane
- Department of Neonatology, University Hospital Galway, Galway, Ireland
| | - A Binchy
- Department of Neonatology, University Hospital Galway, Galway, Ireland
| | - J James
- Department of Neonatology, University Hospital Galway, Galway, Ireland
| | - J B Letshwiti
- Department of Neonatology, University Hospital Galway, Galway, Ireland
| |
Collapse
|
27
|
Georas SN, Wright RJ, Ivanova A, Israel E, LaVange LM, Akuthota P, Carr TF, Denlinger LC, Fajt ML, Kumar R, O'Neal WK, Phipatanakul W, Szefler SJ, Aronica MA, Bacharier LB, Burbank AJ, Castro M, Crotty Alexander L, Bamdad J, Cardet JC, Comhair SAA, Covar RA, DiMango EA, Erwin K, Erzurum SC, Fahy JV, Gaffin JM, Gaston B, Gerald LB, Hoffman EA, Holguin F, Jackson DJ, James J, Jarjour NN, Kenyon NJ, Khatri S, Kirwan JP, Kraft M, Krishnan JA, Liu AH, Liu MC, Marquis MA, Martinez F, Mey J, Moore WC, Moy JN, Ortega VE, Peden DB, Pennington E, Peters MC, Ross K, Sanchez M, Smith LJ, Sorkness RL, Wechsler ME, Wenzel SE, White SR, Zein J, Zeki AA, Noel P. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol 2022; 149:488-516.e9. [PMID: 34848210 PMCID: PMC8821377 DOI: 10.1016/j.jaci.2021.10.035] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Revised: 09/24/2021] [Accepted: 10/07/2021] [Indexed: 12/24/2022]
Abstract
Asthma is a heterogeneous disease, with multiple underlying inflammatory pathways and structural airway abnormalities that impact disease persistence and severity. Recent progress has been made in developing targeted asthma therapeutics, especially for subjects with eosinophilic asthma. However, there is an unmet need for new approaches to treat patients with severe and exacerbation-prone asthma, who contribute disproportionately to disease burden. Extensive deep phenotyping has revealed the heterogeneous nature of severe asthma and identified distinct disease subtypes. A current challenge in the field is to translate new and emerging knowledge about different pathobiologic mechanisms in asthma into patient-specific therapies, with the ultimate goal of modifying the natural history of disease. Here, we describe the Precision Interventions for Severe and/or Exacerbation-Prone Asthma (PrecISE) Network, a groundbreaking collaborative effort of asthma researchers and biostatisticians from around the United States. The PrecISE Network was designed to conduct phase II/proof-of-concept clinical trials of precision interventions in the population with severe asthma, and is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Using an innovative adaptive platform trial design, the PrecISE Network will evaluate up to 6 interventions simultaneously in biomarker-defined subgroups of subjects. We review the development and organizational structure of the PrecISE Network, and choice of interventions being studied. We hope that the PrecISE Network will enhance our understanding of asthma subtypes and accelerate the development of therapeutics for severe asthma.
Collapse
Affiliation(s)
- Steve N Georas
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, Rochester, NY.
| | | | - Anastasia Ivanova
- Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
| | - Elliot Israel
- Department of Medicine, Divisions of Pulmonary & Critical Care Medicine & Allergy & Immunology, Brigham & Women's Hospital, Harvard Medical School, Boston, Mass
| | - Lisa M LaVange
- Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
| | - Praveen Akuthota
- Pulmonary Division, Department of Medicine, University of California-San Diego, La Jolla, Calif
| | - Tara F Carr
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz
| | - Loren C Denlinger
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis
| | - Merritt L Fajt
- University of Pittsburgh Asthma Institute, University of Pittsburgh, Pittsburgh, Pa
| | | | - Wanda K O'Neal
- Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, NC
| | | | - Stanley J Szefler
- Children's Hospital Colorado, Aurora, Colo; University of Colorado School of Medicine, Aurora, Colo
| | - Mark A Aronica
- Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
| | | | - Allison J Burbank
- Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, NC
| | - Mario Castro
- University of Kansas School of Medicine, Kansas City, Mo
| | - Laura Crotty Alexander
- Pulmonary Division, Department of Medicine, University of California-San Diego, La Jolla, Calif
| | - Julie Bamdad
- Division of Lung Diseases, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Md
| | | | | | | | | | - Kim Erwin
- Institute for Healthcare Delivery Design, University of Illinois at Chicago, Chicago, Ill
| | | | - John V Fahy
- University of California, San Francisco School of Medicine, San Francisco, Calif
| | | | - Benjamin Gaston
- Wells Center for Pediatric Research, Indiana University, Indianapolis, Ind
| | - Lynn B Gerald
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz
| | - Eric A Hoffman
- Department of Radiology, University of Iowa, Iowa City, Iowa
| | | | - Daniel J Jackson
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis
| | - John James
- Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
| | - Nizar N Jarjour
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis
| | - Nicholas J Kenyon
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of California Davis School of Medicine, Davis, Calif
| | - Sumita Khatri
- Respiratory Institute, Cleveland Clinic, Cleveland, Ohio
| | - John P Kirwan
- Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, La
| | - Monica Kraft
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz
| | - Jerry A Krishnan
- Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Ill
| | - Andrew H Liu
- Children's Hospital Colorado, Aurora, Colo; University of Colorado School of Medicine, Aurora, Colo
| | - Mark C Liu
- Pulmonary and Critical Care Medicine, Department of Medicine, the Johns Hopkins University, Baltimore, Md
| | - M Alison Marquis
- Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
| | - Fernando Martinez
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz
| | - Jacob Mey
- Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, La
| | - Wendy C Moore
- Wake Forest University School of Medicine, Winston-Salem, NC
| | - James N Moy
- Rush University Medical Center, Chicago, Ill
| | - Victor E Ortega
- Wake Forest University School of Medicine, Winston-Salem, NC
| | - David B Peden
- Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, NC
| | | | - Michael C Peters
- University of California, San Francisco School of Medicine, San Francisco, Calif
| | - Kristie Ross
- The Cleveland Clinic, Cleveland, Ohio; UH Rainbow Babies and Children's Hospitals, Cleveland, Ohio
| | - Maria Sanchez
- Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
| | | | - Ronald L Sorkness
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis
| | - Michael E Wechsler
- Children's Hospital Colorado, Aurora, Colo; University of Colorado School of Medicine, Aurora, Colo
| | - Sally E Wenzel
- University of Pittsburgh Asthma Institute, University of Pittsburgh, Pittsburgh, Pa
| | - Steven R White
- Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Ill
| | - Joe Zein
- Respiratory Institute, Cleveland Clinic, Cleveland, Ohio
| | - Amir A Zeki
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of California Davis School of Medicine, Davis, Calif
| | - Patricia Noel
- Division of Lung Diseases, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Md
| |
Collapse
|
28
|
James J, Hardeman W, Eborall H, Goodall M, Wilding J. The development of PARIS (Physical Activity and sedentaRy behavIour after bariatric Surgery). Physiotherapy 2022. [DOI: 10.1016/j.physio.2021.12.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
James J, Jose J, Gafoor VA. Levetiracetam-induced gingival hyperplasia. J Postgrad Med 2022; 68:168-169. [PMID: 35848684 PMCID: PMC9733520 DOI: 10.4103/jpgm.jpgm_1059_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the newer ones. A 14-year-old boy was started on levetiracetam 250 mg twice daily after a generalized seizure. Five days later he presented with gingival swelling and painful oral aphthae, without lymphadenopathy or systemic symptoms. Blood investigations were normal. After one-month of stopping the drug, the lesions cleared. This case highlights the importance of maintaining good oral hygiene and periodic dental review in patients on antiseizure medications.
Collapse
Affiliation(s)
- J James
- Department of Neurology, Government Medical College, Kozhikode, Kerala, India
| | - J Jose
- Department of Neurology, Government Medical College, Kozhikode, Kerala, India,Address for correspondence: Prof. Jose J, E-mail:
| | - VA Gafoor
- Department of Neurology, Government Medical College, Kozhikode, Kerala, India
| |
Collapse
|
30
|
Lee A, James J, Whisker L, Rakha EA, Ellis IO. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised? Ann R Coll Surg Engl 2021; 104:361-366. [PMID: 34939848 DOI: 10.1308/rcsann.2021.0208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
INTRODUCTION A recent Association of Breast Surgery summary statement on fibroadenoma management recommends excision only for cellular fibroepithelial lesions and rapidly growing lesions with a core biopsy diagnosis of fibroadenoma; persistent pain is a relative indication for excision. METHODS This retrospective study looked at the impact this approach would have on the diagnosis of phyllodes tumours. RESULTS From 2014 to 2018, there were 1,058 core biopsy diagnoses of fibroadenoma; 112 lesions were excised, of which 98 were fibroadenomas, 4 were hamartomas and 10 were phyllodes tumours. In this group, an excision diagnosis of phyllodes tumour was associated with size more than 40 mm, age more than 40 years and radiological suspicion of phyllodes tumour or carcinoma. One hundred and sixty-six excised fibroepithelial lesions with no previous core biopsy included eight phyllodes tumours; in this group, rapid growth was associated with phyllodes tumour diagnosis. Twelve of the 26 fibroepithelial lesions classified as B3 (cellular fibroepithelial lesion or phyllodes tumour) were diagnosed as phyllodes tumours on excision. Using a combination of radiological, clinical and pathological features it was possible to create an excision policy that would recommend excision of 22 of the 31 phyllodes tumours in this period. Eight of the nine 'missed' phyllodes tumours were benign. CONCLUSION The Association of Breast Surgery summary statement will reduce the number of fibroadenomas excised, but may also result in delayed diagnosis of some phyllodes tumours. Appropriate safety netting advice should be provided to identify rapidly growing lesions.
Collapse
Affiliation(s)
- Ahs Lee
- Nottingham University Hospitals NHS Trust, UK
| | - J James
- Breast Institute, Nottingham University Hospitals NHS Trust, UK
| | - L Whisker
- Breast Institute, Nottingham University Hospitals NHS Trust, UK
| | - E A Rakha
- Nottingham University Hospitals NHS Trust, UK
| | - I O Ellis
- Nottingham University Hospitals NHS Trust, UK
| |
Collapse
|
31
|
Lazris A, Roth AR, Haskell H, James J. Prediabetes Diagnosis: Helpful or Harmful? Am Fam Physician 2021; 104:649-651. [PMID: 34913659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
| | - Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, NY, USA
| | | | | |
Collapse
|
32
|
Hamid S, James J, Taylor L, Good D. The learning curve for DVC sparing RARP with anterior reconstruction: A single surgeon experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)02219-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
33
|
James J, Drummond L, Clancy N, Leung S. 1328 A Risk Stratified Post-Nephrectomy Surveillance Protocol – 5-Year Assessment of Performance. Br J Surg 2021. [DOI: 10.1093/bjs/znab259.1108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Introduction
Recurrence rate of surgically treated localised renal cell carcinoma (RCC) is reported to be approximately 20%. There is lack of consensus on the optimal surveillance regimen. We assess the performance of our surveillance protocol based upon prognostic histological factors. We report the outcome of our first cohort to reach 5 years follow up.
Method
A retrospective analysis was performed of patients who underwent a radical or partial nephrectomy between March 2014 and October 2015. Patients were classified as high, intermediate, or low risk based on pathology; with each group undergoing individualised radiological follow up.
Results
80 patients with pathologically confirmed RCC who underwent partial or radical nephrectomy were identified. Recurrence was noted in 24% (n = 19), and a third of those patients (n = 7) died within the 5-year follow-up period. 79% (n = 15) of patients with recurrence were of intermediate or high-risk group. 90% of recurrences were picked up on surveillance scans, 5% due to symptoms related to the recurrence and 5% incidentally. 70% occurred within the first 2 years post-surgery. 92% (n = 6) of those who died had an ASA of 2 or higher. In the whole cohort, total number of deaths was 13. 38% (n = 5) died of RCC, 54% (n = 7) died of other causes and in 8% (n = 1) cause of death of was unclear.
Conclusions
Our risk stratified surveillance protocol identified 90% of recurrences within the 5-year follow-up. Future refinement of our protocol could include an assessment of performance status which may influence the schedule of radiological surveillance.
Collapse
Affiliation(s)
- J James
- Department of Urology, Western General Hospital, Edinburgh, United Kingdom
| | - L Drummond
- Department of Urology, Western General Hospital, Edinburgh, United Kingdom
| | - N Clancy
- The University of Edinburgh, Edinburgh, United Kingdom
| | - S Leung
- Department of Urology, Western General Hospital, Edinburgh, United Kingdom
| |
Collapse
|
34
|
Gilbert FJ, Hickman SE, Baxter GC, Allajbeu I, James J, Caraco C, Vinnicombe S. Opportunities in cancer imaging: risk-adapted breast imaging in screening. Clin Radiol 2021; 76:763-773. [PMID: 33820637 DOI: 10.1016/j.crad.2021.02.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Accepted: 02/19/2021] [Indexed: 12/17/2022]
Abstract
In the UK, women between 50-70 years are invited for 3-yearly mammography screening irrespective of their likelihood of developing breast cancer. The only risk adaption is for women with >30% lifetime risk who are offered annual magnetic resonance imaging (MRI) and mammography, and annual mammography for some moderate-risk women. Using questionnaires, breast density, and polygenic risk scores, it is possible to stratify the population into the lowest 20% risk, who will develop <4% of cancers and the top 4%, who will develop 18% of cancers. Mammography is a good screening test but has low sensitivity of 60% in the 9% of women with the highest category of breast density (BIRADS D) who have a 2.5- to fourfold breast cancer risk. There is evidence that adding ultrasound to the screening mammogram can increase the cancer detection rate and reduce advanced stage interval and next round cancers. Similarly, alternative tests such as contrast-enhanced mammography (CESM) or abbreviated MRI (ABB-MRI) are much more effective in detecting cancer in women with dense breasts. Scintimammography has been shown to be a viable alternative for dense breasts or for follow-up in those with a personal history of breast cancer and scarring as result of treatment. For supplemental screening to be worthwhile in these women, new technologies need to reduce the number of stage II cancers and be cost effective when tested in large scale trials. This article reviews the evidence for supplemental imaging and examines whether a risk-stratified approach is feasible.
Collapse
Affiliation(s)
- F J Gilbert
- Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Level 5, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK; Department of Radiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
| | - S E Hickman
- Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Level 5, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - G C Baxter
- Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Level 5, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - I Allajbeu
- Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Level 5, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK; Department of Radiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - J James
- Nottingham Breast Institute, City Hospital, Nottingham, UK
| | - C Caraco
- Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Level 5, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - S Vinnicombe
- Thirlestaine Breast Centre, Cheltenham, UK; Ninewells Hospital and Medical School, University of Dundee, UK
| |
Collapse
|
35
|
Abstract
BACKGROUND Intranasal corticosteroids are widely used for management of many upper airway diseases because of their ability to effectively deliver local relief of inflammation. CASE REPORT This paper presents the case of a 51-year-old man with human immunodeficiency virus treated with ritonavir who was started on fluticasone intranasal spray for presumed chronic rhinosinusitis. Months after starting this therapy, he developed symptoms of Cushing's syndrome and avascular necrosis of the shoulder due to the pharmacological interactions between fluticasone and ritonavir. CONCLUSION Although intranasal corticosteroids are deemed a low-risk route of drug administration, clinicians need to be vigilant in appropriately prescribing corticosteroids in the setting of drug potentiators, particularly in these high-risk patients. Alternative corticosteroids such as beclomethasone dipropionate should be considered in such cases.
Collapse
Affiliation(s)
- J James
- City University of New York School of Medicine, USA
| | - L Caulley
- Department of Otolaryngology - Head and Neck Surgery, University of Ottawa, Ottawa Hospital, Canada
- Department of Clinical Epidemiology, Ottawa Hospital Research Institute, Canada
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands
| | - J Collins
- ENT Department, Guy's Hospital, London, UK
| | - C Hopkins
- ENT Department, Guy's Hospital, London, UK
| |
Collapse
|
36
|
Lazris A, Roth AR, Haskell H, James J. Efficient Approach to the Evaluation of Syncope. Am Fam Physician 2021; 104:305-308. [PMID: 34523881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Affiliation(s)
| | - Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, NY, USA
| | | | | |
Collapse
|
37
|
James J, Arthi C, Balaji G, Chandraleka N, Naveen Kumar RHM. Lime activated flyash-phosphogypsum blend as a low-cost alternative binder. Int J Environ Sci Technol (Tehran) 2021; 19:8969-8978. [PMID: 34484366 PMCID: PMC8404028 DOI: 10.1007/s13762-021-03618-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Revised: 07/21/2021] [Accepted: 08/15/2021] [Indexed: 06/13/2023]
Abstract
This study investigates the potential of a blended binder formulated from two industrial solid wastes viz. phosphogypsum and fly ash in combination with lime. Three mix proportions of phosphogypsum and fly ash were investigated, and the minimum lime contents required for activation were determined using the Eades and Grim pH test. The lime-fly ash-phosphogypsum blends were then cast into cubes, both in their paste form as well as mortar form, mixed with sand in the ratio of 1:3. They were cured for a period of seven days, and afterwards, their compressive strength was determined. Ordinary Portland cement and lime mortar blocks were also cast as control specimens for comparative evaluation of the strength. The optimal lime-fly ash-phosphogypsum blend was identified and used to construct a masonry prism, and the strengths of the masonry prisms were also evaluated. The optimal lime-fly ash-phosphogypsum blend mortar was also subjected to an X-ray diffraction analysis to determine the reaction products formed during hydration. The study revealed that 5% lime mixed with fly ash:phosphogypsum in the ratio of 3:1 was the optimal proportion which gave the maximum strength to the cubes. The optimal lime-fly ash-phosphogypsum blend mortar developed strength that was higher than conventional Portland cement and lime mortar. The optimal lime-fly ash-phosphogypsum blend mortar masonry prisms developed strength that was comparable to that of Portland cement mortar masonry. The X-ray diffraction analysis revealed the formation of calcium silicate hydrate minerals as well as ettringite and portlandite which were responsible for strength gain.
Collapse
Affiliation(s)
- J. James
- Sri Sivasubramaniya Nadar College of Engineering, Kalavakkam, Chennai, 603110 India
| | - C. Arthi
- Tagore Engineering College, Rathinamangalam, Chennai, 600127 India
| | - G. Balaji
- Tagore Engineering College, Rathinamangalam, Chennai, 600127 India
| | - N. Chandraleka
- Tagore Engineering College, Rathinamangalam, Chennai, 600127 India
| | | |
Collapse
|
38
|
Lazris A, Roth AR, Haskell H, James J. Poor Physician-Patient Communication and Medical Error. Am Fam Physician 2021; 103:757-759. [PMID: 34128617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
| | - Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, NY, USA
| | | | | |
Collapse
|
39
|
James J, Drummond L, Taylor L, Mcneill S, Good D. Beware excluding systematic biopsy in patients undergoing radical prostatectomy: A five year follow up study of biochemical recurrence free survival. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01319-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Osunkwo I, Andemariam B, Minniti CP, Inusa BPD, El Rassi F, Francis‐Gibson B, Nero A, Trimnell C, Abboud MR, Arlet J, Colombatti R, Montalembert M, Jain S, Jastaniah W, Nur E, Pita M, DeBonnett L, Ramscar N, Bailey T, Rajkovic‐Hooley O, James J. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol 2021; 96:404-417. [PMID: 33264445 PMCID: PMC8248107 DOI: 10.1002/ajh.26063] [Citation(s) in RCA: 53] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 11/26/2020] [Accepted: 11/29/2020] [Indexed: 12/20/2022]
Abstract
Sickle cell disease (SCD) is a genetic disorder, characterized by hemolytic anemia and vaso‐occlusive crises (VOCs). Data on the global SCD impact on quality of life (QoL) from the patient viewpoint are limited. The international Sickle Cell World Assessment Survey (SWAY) aimed to provide insights into patient‐reported impact of SCD on QoL. This cross‐sectional survey of SCD patients enrolled by healthcare professionals and advocacy groups assessed disease impact on daily life, education and work, symptoms, treatment goals, and disease management. Opinions were captured using a Likert scale of 1‐7 for some questions; 5‐7 indicated “high severity/impact.” Two thousand one hundred and forty five patients (mean age 24.7 years [standard deviation (SD) = 13.1], 39% ≤18 years, 52% female) were surveyed from 16 countries (six geographical regions). A substantial proportion of patients reported that SCD caused a high negative impact on emotions (60%) and school achievement (51%) and a reduction in work hours (53%). A mean of 5.3 VOCs (SD = 6.8) was reported over the 12 months prior to survey (median 3.0 [interquartile range 2.0‐6.0]); 24% were managed at home and 76% required healthcare services. Other than VOCs, fatigue was the most commonly reported symptom in the month before survey (65%), graded “high severity” by 67% of patients. Depression and anxiety were reported by 39% and 38% of patients, respectively. The most common patient treatment goal was improving QoL (55%). Findings from SWAY reaffirm that SCD confers a significant burden on patients, epitomized by the high impact on patientsʼ QoL and emotional wellbeing, and the high prevalence of self‐reported VOCs and other symptoms.
Collapse
Affiliation(s)
- Ifeyinwa Osunkwo
- Sickle Cell Disease Enterprise The Levine Cancer Institute, Atrium Health Charlotte North Carolina USA
| | - Biree Andemariam
- New England Sickle Cell Institute, University of Connecticut Health Farmington Connecticut USA
| | | | - Baba P. D. Inusa
- Evelina Childrenʼs Hospital Guyʼs and St Thomasʼ NHS Foundation Trust London UK
| | - Fuad El Rassi
- Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System Atlanta Georgia USA
| | | | - Alecia Nero
- University of Texas Southwestern Medical Center Dallas Texas USA
| | | | | | - Jean‐Benoît Arlet
- Sickle Cell Disease Referral Centre, Internal Medicine Department, Hôpital Européen Georges‐Pompidou, AP‐HP Université de Paris Paris France
| | | | | | - Suman Jain
- Thalassemia and Sickle Cell Society Hyderabad India
| | | | - Erfan Nur
- Academic Medical Center Amsterdam The Netherlands
| | - Marimilia Pita
- Pediatric Hematology, Hospital Samaritano Laureate University‐UAM São Paulo Brazil
| | - Laurie DeBonnett
- Novartis Pharmaceuticals Corporation East Hanover New Jersey USA
| | | | | | | | | |
Collapse
|
41
|
Seekings AH, Warren CJ, Thomas SS, Mahmood S, James J, Byrne AMP, Watson S, Bianco C, Nunez A, Brown IH, Brookes SM, Slomka MJ. Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry. Virology 2021; 559:74-85. [PMID: 33839461 DOI: 10.1016/j.virol.2021.03.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 03/12/2021] [Accepted: 03/14/2021] [Indexed: 10/21/2022]
Abstract
Highly-pathogenic avian influenza virus (HPAIV) H5N6 (clade 2.3.4.4b) incurred into Europe in late 2017 and was predominantly detected in wild birds, with very few terrestrial poultry cases. Pekin ducks directly-infected with a UK virus (H5N6-2017) were donors of infection to investigate contact transmission to three recipient species: Ducks, chickens and turkeys. H5N6-2017 transmission to ducks was 100% efficient, but transmission to in-contact galliforme species was infrequent and unpredictable, thereby reflecting the European 2017-2018 H5N6 epidemiology. Although only two of 28 (7%) infected ducks died, the six turkeys and one chicken which became infected all died and displayed systemic H5N6-2017 dissemination, while pathogenesis in ducks was generally milder. Analysis of H5N6-2017 progeny in the contacts revealed no emergent polymorphisms in an infected duck, but the galliforme species included changes in the polymerase (PB2 A199T, PA D347A), matrix (M1 T218A) and neuraminidase genes (T88I). H5N6-2017 environmental contamination was associated with duck shedding.
Collapse
Affiliation(s)
- A H Seekings
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - C J Warren
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - S S Thomas
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - S Mahmood
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - J James
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - A M P Byrne
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - S Watson
- Animal Sciences Unit, APHA-Weybridge, Addlestone, Surrey, KT15 3NB, UK
| | - C Bianco
- Pathology Department, APHA-Weybridge, Addlestone, Surrey, KT15 3NB, UK
| | - A Nunez
- Pathology Department, APHA-Weybridge, Addlestone, Surrey, KT15 3NB, UK
| | - I H Brown
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - S M Brookes
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK
| | - M J Slomka
- Avian Virology and Mammalian Influenza Research, Virology Department, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, KT15 3NB, UK.
| |
Collapse
|
42
|
Glaseroff A, Lindsay A, Haskell H, James J. Helping Ambivalent Patients Make Healthy Decision About COVID-19. Am Fam Physician 2021; 103:334-336. [PMID: 33719372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
- Alan Glaseroff
- Stanford Clinical Excellence Research Center, Stanford, CA, USA
| | - Ann Lindsay
- Stanford University School of Medicine, Stanford, CA, USA
| | | | | |
Collapse
|
43
|
Sommariva S, Mote J, Ballester Bon H, Razafindraibe H, Ratovozanany D, Rasoamanana V, Abeyesekera S, Muhamedkhojaeva P, Bashar T, James J, Sani M. Social Listening in Eastern and Southern Africa, a UNICEF Risk Communication and Community Engagement Strategy to Address the COVID-19 Infodemic. Health Secur 2021; 19:57-64. [PMID: 33606573 PMCID: PMC9195494 DOI: 10.1089/hs.2020.0226] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has been closely tied with what has been called an infodemic, a “second disease” that occurs when massive information volumes (particularly with a high prevalence of false information) hinder the public health response. In this context, social listening, the process of monitoring and analyzing conversations to inform strategic activities both online and offline, becomes an even more essential component of risk communication and engagement strategies. In the Eastern and Southern Africa region, the United Nations Children's Fund (UNICEF) and partners in the response have activated their capacity to gather insights on the information needs of the populations served to better inform and engage with local communities. We describe the social listening approach taken at the Eastern and Southern Africa regional level to respond to COVID-19 and highlight efforts by the Comoros, Kenya, Madagascar, Malawi, and Zambia UNICEF country offices to implement digital and nondigital social listening to inform risk communication and community engagement. The analysis highlights channels leveraged, types of data monitored, and provides examples of social listening data use, as well as early challenges and lessons learned.
Collapse
Affiliation(s)
- Silvia Sommariva
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Jenna Mote
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Helena Ballester Bon
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Herisoa Razafindraibe
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Domoina Ratovozanany
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Vanou Rasoamanana
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Surangani Abeyesekera
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Parvina Muhamedkhojaeva
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Tasmia Bashar
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - John James
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| | - Massimiliano Sani
- Silvia Sommariva, MPA, MSc, and Jenna Mote, MPH, are Consultants, Communication for Development (C4D), United Nations Children's Fund (UNICEF) Eastern and Southern Africa Regional Office, New York, NY. Helena Ballester Bon, MA, and Massimiliano Sani, MA, are Specialists, C4D, UNICEF Eastern and Southern Africa Regional Office, Nairobi, Kenya. Herisoa Razafindraibe, MRes, is a Specialist and Domoina Ratovozanany, MA, is an Officer, C4D, UNICEF Madagascar Country Office, Antananarivo, Madagascar. Vanou Rasoamanana, MA, is a Specialist, C4D, UNICEF Comoros Country Office, Moroni, Comoros. Surangani Abeyesekera, PG, is a Manager, C4D, UNICEF Kenya Country Office, Nairobi, Kenya. Parvina Muhamedkhojaeva, PhD, is a Manager, C4D, UNICEF Malawi Country Office, Lilongwe, Malawi. Tasmia Bashar, MSc, MA, is a Specialist, C4D; and John James, MSc, is Chief, Communications; both in the UNICEF Zambia Country Office, Lusaka, Zambia
| |
Collapse
|
44
|
Lindsay A, Haskell H, James J. Preoperative Evaluation and Frailty Assessment in Older Patients. Am Fam Physician 2020; 102:753-755. [PMID: 33320514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
- Ann Lindsay
- Stanford University School of Medicine, Stanford, CA, USA
| | | | | |
Collapse
|
45
|
Kästle M, Merten C, Hartig R, Kaehne T, Liaunardy-Jopeace A, Woessner NM, Schamel WW, James J, Minguet S, Simeoni L, Schraven B. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56 Lck regulates T-cell activation independently of Lck/CD45 interactions. Cell Commun Signal 2020; 18:183. [PMID: 33225946 PMCID: PMC7682018 DOI: 10.1186/s12964-020-00673-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Accepted: 10/13/2020] [Indexed: 01/09/2023] Open
Abstract
BACKGROUND Upon engagement of the T-cell receptor (TCR), the Src-family protein tyrosine kinase p56Lck phosphorylates components of the TCR (e.g. the TCRζ chains), thereby initiating T-cell activation. The enzymatic activity of Lck is primarily regulated via reversible and dynamic phosphorylation of two tyrosine residues, Y394 and Y505. Lck possesses an additional highly conserved tyrosine Y192, located within the SH2 domain, whose role in T-cell activation is not fully understood. METHODS Knock-in mice expressing a phospho-mimetic (Y192E) form of Lck were generated. Cellular and biochemical characterization was performed to elucidate the function of Y192 in primary T cells. HEK 293T and Jurkat T cells were used for in vitro studies. RESULTS Co-immunoprecipitation studies and biochemical analyses using T cells from LckY192E knock-in mice revealed a diminished binding of LckY192E to CD45 and a concomitant hyperphosphorylation of Y505, thus corroborating previous data obtained in Jurkat T cells. Surprisingly however, in vitro kinase assays showed that LckY192E possesses a normal enzymatic activity in human and murine T cells. FLIM/FRET measurements employing an LckY192E biosensor further indicated that the steady state conformation of the LckY192E mutant is similar to Lckwt. These data suggest that Y192 might regulate Lck functions also independently from the Lck/CD45-association. Indeed, when LckY192E was expressed in CD45-/-/Csk-/- non-T cells (HEK 293T cells), phosphorylation of Y505 was similar to Lckwt, but LckY192E still failed to optimally phosphorylate and activate the Lck downstream substrate ZAP70. Furthermore, LckY19E was recruited less to CD3 after TCR stimulation. CONCLUSIONS Taken together, phosphorylation of Y192 regulates Lck functions in T cells at least twofold, by preventing Lck association to CD45 and by modulating ligand-induced recruitment of Lck to the TCR. MAJOR FINDINGS Our data change the current view on the function of Y192 and suggest that Y192 also regulates Lck activity in a manner independent of Y505 phosphorylation. Video Abstract.
Collapse
Affiliation(s)
- Matthias Kästle
- Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.,Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - Camilla Merten
- Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.,Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - Roland Hartig
- Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.,Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | - Thilo Kaehne
- Institute of Experimental Internal Medicine, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
| | | | - Nadine M Woessner
- Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany.,Faculty of Biology, Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.,Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany
| | - Wolfgang W Schamel
- Faculty of Biology, Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.,Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany
| | - John James
- Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC-LMB, Cambridge, UK.,Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK
| | - Susana Minguet
- Faculty of Biology, Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.,Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany
| | - Luca Simeoni
- Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany. .,Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
| | - Burkhart Schraven
- Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany. .,Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
| |
Collapse
|
46
|
Pita M, James J, Forny S, Ramscar N, Osunkwo I. USE OF OPIOIDS AND BURDEN OF DISEASE IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) IN BRAZIL VS THE OVERALL POPULATION OF THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY). Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
47
|
Abboud M, James J, Ramscar N, Osunkwo I, Sway S. HEALTHCARE PROFESSIONAL (HCP) PERCEPTIONS OF SICKLE CELL DISEASE (SCD): INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY). Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
48
|
Roth AR, Lazris A, Haskell H, James J. Appropriate Use of Opioids for Chronic Pain. Am Fam Physician 2020; 102:335-337. [PMID: 32931211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- Alan R Roth
- Jamaica Hospital Medical Center, Jamaica, NY, USA
| | | | | | | |
Collapse
|
49
|
Dhatariya K, James J, Kong MF, Berrington R. Diabetes at the front door. A guideline for dealing with glucose related emergencies at the time of acute hospital admission from the Joint British Diabetes Society (JBDS) for Inpatient Care Group. Diabet Med 2020; 37:1578-1589. [PMID: 32279343 DOI: 10.1111/dme.14304] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/02/2020] [Indexed: 12/18/2022]
Abstract
People with diabetes account for nearly one-fifth of all inpatients in English and Welsh hospitals; of these, up to 90% are admitted as an emergency. Most are admitted for a reason other than diabetes with only 8% requiring admission for a diabetes-specific cause. Healthcare professionals working in emergency departments experience numerous clinical challenges, notwithstanding the need to know whether each individual with diabetes requires urgent admission. This document has been developed and written by experts in the field, and reviewed by the parent organizations of the Joint British Diabetes Societies for Inpatient Care-Diabetes UK, the Diabetes Inpatient Specialist Nurse Group and the Association of British Clinical Diabetologists. The document aims to support staff working in emergency departments and elsewhere by offering practical advice and tools for effective, appropriate and safe triage. Each section relates to the commonest diabetic specific emergencies and algorithms can be printed off to enable ease of access and use.
Collapse
Affiliation(s)
- K Dhatariya
- Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
- Norwich Medical School, University of East Anglia, Norwich, UK
| | - J James
- Department of Diabetes, University Hospitals Leicester NHS Trust, Leicester, UK
| | - M-F Kong
- Department of Diabetes, University Hospitals Leicester NHS Trust, Leicester, UK
| | - R Berrington
- Department of Diabetes, University Hospitals Leicester NHS Trust, Leicester, UK
| |
Collapse
|
50
|
Zhu J, Tran L, Zheng F, James J, Guthridge J, Chong B. 717 Enhanced molecular signatures in cutaneous lupus erythematosus patients support distinct pathogenic pathways in African American patients. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|